Loading...

Biotin anti-mouse NK-1.1 Antibody

Pricing & Availability
Clone
PK136 (See other available formats)
Regulatory Status
RUO
Other Names
NKR-P1C, NKR-P1B, Ly-55, CD161, CD161b, CD161c
Isotype
Mouse IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
PK136_Biotin_1_110210
C57BL/6 mouse splenocytes were stained with CD49b (DX5) APC and biotinylated NK1.1 (clone PK136) (top) or mouse IgG2a isotype control, followed by Sav-PE (bottom).
  • PK136_Biotin_1_110210
    C57BL/6 mouse splenocytes were stained with CD49b (DX5) APC and biotinylated NK1.1 (clone PK136) (top) or mouse IgG2a isotype control, followed by Sav-PE (bottom).
  • PK136_Biotin_2_110210
Cat # Size Price Quantity Check Availability Save
108703 50 µg 38€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
108704 500 µg 106€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
NK-1+ cells from mouse spleen and bone marrow
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, complement-dependent cytotoxicity3, in vivo depletion4,5,9,10, mediation of in vitro redirected lysis6, blocking of NK cell function7, induction of proliferation8, immunohistochemical staining of frozen sections11, immunofluorescence microscopy11, and spatial biology (IBEX)16,17. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 108712).

Application References
  1. Carlyle JR, et al. 1999. J. Immunol. 162:5917. (IP)
  2. Sentman CL, et al. 1989. Hybridoma 8:605. (IP)
  3. Koo GC, et al. 1984. Hybridoma 3:301. (Cyt)
  4. Sentman CL, et al. 1989. J. Immunol. 142:1847. (Deplete)
  5. Koo GC, et al. 1986. J. Immunol. 137:3742. (Deplete)
  6. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  7. Kung SK, et al. 1999. J. Immunol. 162:5876. (Block)
  8. Reichlin A, et al. 1998. Immunol. Cell Biol. 76:143.
  9. Drobyski W, et al. 1996. Blood 87:5355. (Deplete)
  10. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (Deplete)
  11. Kanwar JR, et al. 2001. J. Natl. Cancer Inst. 93:1541. (IHC, IF)
  12. Kroemer A, et al. 2008. J. Immunol. 180:7818. PubMed
  13. Kim JY, et al. 2009. Exp Mol Med. 30:288. PubMed
  14. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  15. Lee H, et al. 2014. Invest Ophthalmol Vis Sci. 55:2885. PubMed
  16. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  17. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  2. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  3. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  4. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  5. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  6. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  7. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  8. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  9. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  10. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  11. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  12. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  13. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  14. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  15. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  16. Bagadia P, et al. 2019. Nat Immunol. 20:1174. PubMed
  17. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  18. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  19. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  20. Yao M, et al. 2020. Cell. 180(3):502-520. PubMed
  21. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  22. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  23. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  24. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  25. Garza-Rodea A, et al. 2011. PLoS One. 6:e14493. PubMed
  26. Zhu Z, et al. 2013. Proc Natl Acad Sci U S A. 110:1282. PubMed
  27. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  28. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  29. Becklund B, et al. 2016. Sci Rep. 6:30842. PubMed
  30. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  31. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  32. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  33. Matson CA, et al. 2020. Proc Natl Acad Sci U S A. 117:14342. PubMed
  34. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  35. Krueger PD, et al. 2021. Immunity. 54(4):687-701.e4. PubMed
  36. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  37. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  38. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  39. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  40. Hutter K, et al. 2020. FEBS J. . PubMed
  41. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  42. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  43. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  44. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  45. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  46. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  47. Dong S, et al. 2021. Nature. 591:117. PubMed
  48. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  49. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  50. Aschman T, et al. 2021. Int J Mol Sci. 22:. PubMed
  51. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  52. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  53. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  54. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  55. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  56. Zeng Z, et al. 2022. Oncogene. :. PubMed
  57. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  58. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  59. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  60. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  61. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  62. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  63. Wang T, et al. 2020. Blood Sci. 2:79. PubMed
  64. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  65. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  66. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  67. Song R, et al. 2022. Immunology. 165:274. PubMed
  68. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  69. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  70. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  71. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  72. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  73. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  74. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  75. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  76. Li S, et al. 2022. Elife. 11:. PubMed
  77. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
RRID
AB_313390 (BioLegend Cat. No. 108703)
AB_313391 (BioLegend Cat. No. 108704)

Antigen Details

Structure
NKR-P1 gene family
Distribution

NK and NK-T cells in the NK1.1 mouse strains (C57BL, FVB/N, NZB)

Function
NK cell activation, IFN-γ production, cytotoxic granule release
Cell Type
NK cells, NKT cells
Biology Area
Immunology, Innate Immunity
Antigen References

1. Lanier LL. 1997. Immunity 6:371.
2. Yokoyama WM, et al. 1993. Ann. Rev. Immunol. 11:613.
3. Koo GC, et al. 1986. J. Immunol. 137:3742.
4. Giorda R, et al. 1991. J. Immunol. 147:1701.

Gene ID
17059 View all products for this Gene ID
UniProt
View information about NK-1.1 on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.
Go To Top Version: 2    Revision Date: 12-08-2016

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account